Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2017

Publisher Name :
Date: 30-Mar-2017
No. of pages: 105
Inquire Before Buying

In this report, the global Pulmonary Arterial Hypertension (PAH) Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pulmonary Arterial Hypertension (PAH) Medicine in these regions, from 2012 to 2022 (forecast), covering

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Global Pulmonary Arterial Hypertension (PAH) Medicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

- Actelion Pharmaceuticals

- Gilead Sciences

- United Therapeutics Corporation

- GlaxoSmithKline

- Pfizer

- Bayer HealthCare

- Arena Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Endothelin Receptor Antagonists (ERA)

- Prostacyclin And Prostacyclin Analogs

- Phosphodiesterase 5 (PDE-5)

- Soluble Guanylate Cyclase (SGC) Stimulators

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Pulmonary Arterial Hypertension (PAH) Medicine for each application, including

- Secondary Pulmonary Hypertension (SPH)

- Primary Pulmonary Hypertension (PPH)

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2017

Table of Contents
Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2017
1 Pulmonary Arterial Hypertension (PAH) Medicine Market Overview
1.1 Product Overview and Scope of Pulmonary Arterial Hypertension (PAH) Medicine
1.2 Pulmonary Arterial Hypertension (PAH) Medicine Segment by Type (Product Category)
1.2.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share by Type (Product Category) in 2016
1.2.3 Endothelin Receptor Antagonists (ERA)
1.2.4 Prostacyclin And Prostacyclin Analogs
1.2.5 Phosphodiesterase 5 (PDE-5)
1.2.6 Soluble Guanylate Cyclase (SGC) Stimulators
1.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Segment by Application
1.3.1 Pulmonary Arterial Hypertension (PAH) Medicine Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Secondary Pulmonary Hypertension (SPH)
1.3.3 Primary Pulmonary Hypertension (PPH)
1.4 Global Pulmonary Arterial Hypertension (PAH) Medicine Market by Region (2012-2022)
1.4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Pulmonary Arterial Hypertension (PAH) Medicine (2012-2022)
1.5.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Status and Outlook (2012-2022)
1.5.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production Status and Outlook (2012-2022)
2 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Competition by Manufacturers
2.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Production and Share by Manufacturers (2012-2017)
2.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Share by Manufacturers (2012-2017)
2.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Pulmonary Arterial Hypertension (PAH) Medicine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Pulmonary Arterial Hypertension (PAH) Medicine Market Competitive Situation and Trends
2.5.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Concentration Rate
2.5.2 Pulmonary Arterial Hypertension (PAH) Medicine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity and Market Share by Region (2012-2017)
3.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Production and Market Share by Region (2012-2017)
3.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Pulmonary Arterial Hypertension (PAH) Medicine Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption by Region (2012-2017)
4.2 North America Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export, Import (2012-2017)
4.3 Europe Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export, Import (2012-2017)
4.4 China Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export, Import (2012-2017)
4.5 Japan Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export, Import (2012-2017)
4.7 India Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export, Import (2012-2017)
5 Global Pulmonary Arterial Hypertension (PAH) Medicine Production, Revenue (Value), Price Trend by Type
5.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Production and Market Share by Type (2012-2017)
5.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Market Share by Type (2012-2017)
5.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Price by Type (2012-2017)
5.4 Global Pulmonary Arterial Hypertension (PAH) Medicine Production Growth by Type (2012-2017)
6 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Analysis by Application
6.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption and Market Share by Application (2012-2017)
6.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers Profiles/Analysis
7.1 Actelion Pharmaceuticals
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Pulmonary Arterial Hypertension (PAH) Medicine Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Gilead Sciences
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Pulmonary Arterial Hypertension (PAH) Medicine Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Gilead Sciences Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 United Therapeutics Corporation
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Pulmonary Arterial Hypertension (PAH) Medicine Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Pulmonary Arterial Hypertension (PAH) Medicine Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Pfizer
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Pulmonary Arterial Hypertension (PAH) Medicine Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Bayer HealthCare
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Pulmonary Arterial Hypertension (PAH) Medicine Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Bayer HealthCare Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Arena Pharmaceuticals
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Pulmonary Arterial Hypertension (PAH) Medicine Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
8 Pulmonary Arterial Hypertension (PAH) Medicine Manufacturing Cost Analysis
8.1 Pulmonary Arterial Hypertension (PAH) Medicine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Pulmonary Arterial Hypertension (PAH) Medicine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Medicine Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Forecast (2017-2022)
12.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Price and Trend Forecast (2017-2022)
12.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Pulmonary Arterial Hypertension (PAH) Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Pulmonary Arterial Hypertension (PAH) Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Pulmonary Arterial Hypertension (PAH) Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Pulmonary Arterial Hypertension (PAH) Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Pulmonary Arterial Hypertension (PAH) Medicine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Pulmonary Arterial Hypertension (PAH) Medicine
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Endothelin Receptor Antagonists (ERA)
Table Major Manufacturers of Endothelin Receptor Antagonists (ERA)
Figure Product Picture of Prostacyclin And Prostacyclin Analogs
Table Major Manufacturers of Prostacyclin And Prostacyclin Analogs
Figure Product Picture of Phosphodiesterase 5 (PDE-5)
Table Major Manufacturers of Phosphodiesterase 5 (PDE-5)
Figure Product Picture of Soluble Guanylate Cyclase (SGC) Stimulators
Table Major Manufacturers of Soluble Guanylate Cyclase (SGC) Stimulators
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption (K MT) by Applications (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Market Share by Applications in 2016
Figure Secondary Pulmonary Hypertension (SPH) Examples
Figure Primary Pulmonary Hypertension (PPH) Examples
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2012-2022)
Figure North America Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT) Status and Outlook (2012-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Major Players Product Capacity (K MT) (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity (K MT) of Key Manufacturers (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity (K MT) of Key Manufacturers in 2016
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity (K MT) of Key Manufacturers in 2017
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Major Players Product Production (K MT) (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) of Key Manufacturers (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Production Share by Manufacturers (2012-2017)
Figure 2016 Pulmonary Arterial Hypertension (PAH) Medicine Production Share by Manufacturers
Figure 2017 Pulmonary Arterial Hypertension (PAH) Medicine Production Share by Manufacturers
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Major Players Product Revenue (Million USD) (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Manufacturers
Table 2017 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Manufacturers
Table Global Market Pulmonary Arterial Hypertension (PAH) Medicine Average Price (USD/MT) of Key Manufacturers (2012-2017)
Figure Global Market Pulmonary Arterial Hypertension (PAH) Medicine Average Price (USD/MT) of Key Manufacturers in 2016
Table Manufacturers Pulmonary Arterial Hypertension (PAH) Medicine Manufacturing Base Distribution and Sales Area
Table Manufacturers Pulmonary Arterial Hypertension (PAH) Medicine Product Category
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Share of Top 3 Manufacturers
Figure Pulmonary Arterial Hypertension (PAH) Medicine Market Share of Top 5 Manufacturers
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity (K MT) by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity Market Share by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity Market Share by Region (2012-2017)
Figure 2016 Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity Market Share by Region
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Production by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share by Region (2012-2017)
Figure 2016 Global Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share by Region
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) by Region (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Region (2012-2017)
Table 2016 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Region
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT) and Growth Rate (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table North America Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Europe Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table China Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table India Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption (K MT) Market by Region (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Market Share by Region (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Market Share by Region (2012-2017)
Figure 2016 Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption (K MT) Market Share by Region
Table North America Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Import & Export (K MT) (2012-2017)
Table Europe Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Import & Export (K MT) (2012-2017)
Table China Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Import & Export (K MT) (2012-2017)
Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Import & Export (K MT) (2012-2017)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Import & Export (K MT) (2012-2017)
Table India Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Import & Export (K MT) (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Production Share by Type (2012-2017)
Figure Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Type (2012-2017)
Figure 2016 Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Type
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Pulmonary Arterial Hypertension (PAH) Medicine by Type (2012-2017)
Figure 2016 Revenue Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Type
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Price (USD/MT) by Type (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Production Growth by Type (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption (K MT) by Application (2012-2017)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Market Share by Application (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Market Share by Applications (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Market Share by Application in 2016
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Growth Rate by Application (2012-2017)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Growth Rate by Application (2012-2017)
Table Actelion Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Production Growth Rate (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share (2012-2017)
Figure Actelion Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (2012-2017)
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Gilead Sciences Pulmonary Arterial Hypertension (PAH) Medicine Production Growth Rate (2012-2017)
Figure Gilead Sciences Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share (2012-2017)
Figure Gilead Sciences Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Medicine Production Growth Rate (2012-2017)
Figure United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share (2012-2017)
Figure United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Medicine Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share (2012-2017)
Figure GlaxoSmithKline Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Production Growth Rate (2012-2017)
Figure Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share (2012-2017)
Figure Pfizer Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (2012-2017)
Table Bayer HealthCare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer HealthCare Pulmonary Arterial Hypertension (PAH) Medicine Production Growth Rate (2012-2017)
Figure Bayer HealthCare Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share (2012-2017)
Figure Bayer HealthCare Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Production Growth Rate (2012-2017)
Figure Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share (2012-2017)
Figure Arena Pharmaceuticals Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pulmonary Arterial Hypertension (PAH) Medicine
Figure Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
Figure Pulmonary Arterial Hypertension (PAH) Medicine Industrial Chain Analysis
Table Raw Materials Sources of Pulmonary Arterial Hypertension (PAH) Medicine Major Manufacturers in 2016
Table Major Buyers of Pulmonary Arterial Hypertension (PAH) Medicine
Table Distributors/Traders List
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Capacity, Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Price (Million USD) and Trend Forecast (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) Forecast by Region (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share Forecast by Region (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption (K MT) Forecast by Region (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption Market Share Forecast by Region (2017-2022)
Figure North America Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) and Growth Rate Forecast (2017-2022)
Figure North America Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) and Growth Rate Forecast (2017-2022)
Figure China Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) and Growth Rate Forecast (2017-2022)
Figure India Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Pulmonary Arterial Hypertension (PAH) Medicine Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) Forecast by Type (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Production (K MT) Forecast by Type (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share Forecast by Type (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Price Forecast by Type (2017-2022)
Table Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption (K MT) Forecast by Application (2017-2022)
Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Consumption (K MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • Investigation Report on Chinese Valsartan Market, 2018-2022
    Published: 05-Jul-2018        Price: US 2200 Onwards        Pages: 30
    Description Valsartan is an angiotensin II receptor antagonist which blocks the angiotensin II receptor type I (AT1), increases the plasma level of angiotensin II, stimulates unblocked AT2 receptor, and counteracts the effects of AT1 receptor to dilate blood vessels and lower blood pressure. Valsartan tablets are mainly used to treat mild to moderate primary hypertension. The growing economy has greatly changed the life style and diet of Chinese people and led......
  • Global Calcium Channel Blocker Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 29-Jun-2018        Price: US 3480 Onwards        Pages: 136
    Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way. ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Calcium Channel Blocker Market 2018, Forecast to 2023
    Published: 29-Jun-2018        Price: US 4880 Onwards        Pages: 135
    Calcium channel blockers(CCBs) are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way. ......
  • United States Indapamide Market Report 2018
    Published: 19-Jun-2018        Price: US 3800 Onwards        Pages: 112
    In this report, the United States Indapamide market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Indap......
  • Global Pulmonary Arterial Hypertension (PAH) Sales Market Report 2018
    Published: 18-Jun-2018        Price: US 4000 Onwards        Pages: 109
    This report studies the global Pulmonary Arterial Hypertension (PAH) market status and forecast, categorizes the global Pulmonary Arterial Hypertension (PAH) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Pulmonary hypertension is a condition of increased blood pressure within the arterie......
  • Global Pulmonary Arterial Hypertension (PAH) Market Research Report 2018
    Published: 18-Jun-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pulmonary Arterial Hypertension (PAH) market status and forecast, categorizes the global Pulmonary Arterial Hypertension (PAH) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Pulmonary hypertension is a condition of increased blood pressure within the arteries of the lungs.[6] Symptoms include shortness o......
  • Global Antihypertensive Drugs Market Research Report 2018
    Published: 18-Jun-2018        Price: US 2900 Onwards        Pages: 94
    This report studies the global Antihypertensive Drugs market status and forecast, categorizes the global Antihypertensive Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Antihypertensive Drugs market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.......
  • United States Calcium Channel Blocker Market Report 2018
    Published: 18-Jun-2018        Price: US 3800 Onwards        Pages: 102
    In this report, the United States Calcium Channel Blocker market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ......
  • Global and China Hypertension Drugs Market Research by Company, Type & Application 2013-2025
    Published: 13-Jun-2018        Price: US 2000 Onwards        Pages: 88
    Summary Market Segment as follows: By Type - Systemic hypertension drugs - Pulmonary hypertension drugs By Application - Drugstore - Hospital - Others By Company - Novartis - Daiichi Sankyo - Actelion Pharmaceuticals - Boehringer Ingelheim - Sanofi - Pfizer - Actelion Pharmaceuticals - Bayer - Johnson & Johnson - Merck The ma......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs